NCT07245654

Brief Summary

Perioperative assessment of adequate depth of anesthesia and analgesia is currently a recommended part of routine anesthesia practice for all surgical procedures. In most cases, it is performed by monitoring and evaluating physiological parameters, which is insufficient, especially for the depth of anesthesia. The depth of anesthesia, when measured with the Conox device, is indicated by the qCON index, the recommended value for anesthesia management is between 40-60. Shallow (above 60) anesthesia may be associated with an increased incidence of perioperative wakefulness episodes, and deeper (below 40) anesthesia may lead to a more frequent occurrence of adverse effects of anesthesia, including emergent delirium in the postoperative period. In addition to assessing the depth of anesthesia, the Conox device also allows for instrumental assessment of analgesia. Inadequate analgesia increases postoperative discomfort and may contribute to an increased incidence of complications in anesthesia and during the postoperative period. Instrumental monitoring of the depth of anesthesia and analgesia increases the safety of anesthesia care. During perioperative care, periods with significant painful stimulation include not only the surgical procedure itself but also airway management during induction of general anesthesia, especially intubation. The hypothesis is - due to the significant painful stimulation during airway management during induction of anesthesia, adequate depth of anesthesia and analgesia may be insufficient and is associated with the patient's clinical response, which may be associated with the occurrence of postoperative delirium.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
8mo left

Started Nov 2025

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress43%
Nov 2025Dec 2026

Study Start

First participant enrolled

November 10, 2025

Completed
4 days until next milestone

First Submitted

Initial submission to the registry

November 14, 2025

Completed
10 days until next milestone

First Posted

Study publicly available on registry

November 24, 2025

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2026

Last Updated

November 24, 2025

Status Verified

November 1, 2025

Enrollment Period

1.1 years

First QC Date

November 14, 2025

Last Update Submit

November 17, 2025

Conditions

Keywords

depth of anesthesiapediatricnociceptionawarenessdepth of analgesiaairway management

Outcome Measures

Primary Outcomes (1)

  • Depth of anesthesia

    Assessment of the depth of anesthesia, level of analgesia during airway management during induction of anesthesia, clinical response of the patient.

    Perioperative/Periprocedural

Secondary Outcomes (1)

  • contributing factors

    Perioperative/Periprocedural

Eligibility Criteria

Age1 Year - 19 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)
Sampling MethodProbability Sample
Study Population

\- Pediatric patients (age 1-19 years) indicated for surgery under general anesthesia with airway management (laryngeal mask, orotracheal intubation, nasotracheal intubation) with expected duration of surgery more than 30 minutes

You may qualify if:

  • Pediatric patients (age 1-19 years) indicated for surgery under general anesthesia with airway management (laryngeal mask, orotracheal intubation, nasotracheal intubation)
  • CONOX monitoring available

You may not qualify if:

  • Age out of range
  • Use of ketamine during anesthesia care (premedication, analgesic, anesthetic)
  • Expected duration of surgery less than 30 minutes
  • CONOX monitoring unavailable

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Hospital Brno

Brno, 62500, Czechia

RECRUITING

Study Officials

  • Petr Štourač, prof.MD.Ph.D

    University Hospital Brno

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Tereza Bonischova, MD

CONTACT

Hana Harazim, MD, PhD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
prof. MUDr. Petr Štourač, Ph.D., LL.M, MBA, FESAIC

Study Record Dates

First Submitted

November 14, 2025

First Posted

November 24, 2025

Study Start

November 10, 2025

Primary Completion (Estimated)

December 31, 2026

Study Completion (Estimated)

December 31, 2026

Last Updated

November 24, 2025

Record last verified: 2025-11

Data Sharing

IPD Sharing
Will not share

Locations